Corona Remedies Ltd
Corona Remedies | 544644
Share Price Chart - Corona Remedies Ltd
Stock Performance
Ratios
About Company
- Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli
- Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'
- A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024
- The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat)
- The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas
- In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005
- The production of first manufacturing plant was commissioned at Solan, Himachal Pradesh in 2007
- The Company launched Gynaecology division in 2008; further launched Cardioloy division in 2013; launched Cardiovascular disease (CVD) and Solis division in 2016
- Later, the production at Ahmedabad Plant commissioned in Gujarat in 2021
- Radiance and Solaris Divisions launched in 2022; followed by Urology division in 2023
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Corona Remedies Ltd?
The current share price of Corona Remedies Ltd (Corona Remedies) is ₹2047.90. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Corona Remedies Ltd?
The Price-to-Earnings (P/E) ratio of Corona Remedies Ltd is 2047.90. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Corona Remedies Ltd?
Corona Remedies Ltd has a 52-week high of ₹2100.70 and a 52-week low of ₹1336.60. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Corona Remedies Ltd?
Corona Remedies Ltd offers a dividend yield of 0.49%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Corona Remedies Ltd?
The Earnings Per Share (EPS) of Corona Remedies Ltd is ₹32.68. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Corona Remedies Ltd?
Corona Remedies Ltd has a Return on Equity (ROE) of 27.35%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
